Overview Fundamentals API Earnings EOD API Sample Code Pricing

Cerevel Therapeutics Holdings Inc (CERE NASDAQ) stock market data APIs

$41.16 0.85(2.1%) as of July 12, 2024
Price chart is built with Anychart

Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, develops various therapies for neuroscience diseases in the United States. It is developing Emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures or focal epilepsy, as well as in phase 1 trial to treat panic symptoms model. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; and CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and PDE4 inhibitor for the treatment of psychiatric, neuroinflammatory, and other disorders. Cerevel Therapeutics Holdings, Inc. was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Cerevel Therapeutics Holdings Inc Financial Data Overview

40.31
41.16
-
41.16
40.24
19.59-43.5898
7 344 M
182 M
0
-0.73
1.407
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CERE',
Type: 'Common Stock',
Name: 'Cerevel Therapeutics Holdings Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00VCYVLH4',
ISIN: NULL,
CUSIP: NULL,
CIK: '1805387',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-10-28',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Cerevel Therapeutics Holdings Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -484 523 008
  • Earnings Per Share -2.73
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Cerevel Therapeutics Holdings Inc Earnings via APIs

  • Latest Release 2024-05-08
  • EPS/Forecast -0.61

Get Cerevel Therapeutics Holdings Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com